[HTML][HTML] Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory research, 2010 - Springer
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory research, 2010 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - go.gale.com
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
[HTML][HTML] Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - respiratory-research.biomedcentral …
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
[PDF][PDF] Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - 2010 - Citeseer
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - search.ebscohost.com
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
[PDF][PDF] Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - 2010 - scienceopen.com
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - infona.pl
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
DP Tashkin, LM Fabbri - Respiratory Research, 2010 - search.proquest.com
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …